Randy Ban - Inspire Medical Senior Vice President - Sales and Marketing
INSP Stock | USD 233.93 8.71 3.87% |
President
Mr. Randy Ban is a Senior Vice President, Global Sales and Marketing of the Company. Mr. Ban has served as our Senior Vice President, Sales and Marketing from July 2009 to December 2018 and, in December 2018, his title was changed to Senior Vice President, Global Sales and Marketing. Prior to joining us, Mr. Ban served as Chief Operating Officer at Vertebral Technologies Inc., a medical device company, from 2008 to 2009. From 2006 to 2008, Mr. Ban served as Vice President of Global Marketing, CRM at Boston Scientific since 2018.
Age | 53 |
Tenure | 6 years |
Professional Marks | MBA |
Address | 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416 |
Phone | 844 672 4357 |
Web | https://www.inspiresleep.com |
Latest Insider Transactions
Ban holds a B.S. in marketing and an M.B.A., both from Indiana University.Randy Ban Latest Insider Activity
Tracking and analyzing the buying and selling activities of Randy Ban against Inspire Medical stock is an integral part of due diligence when investing in Inspire Medical. Randy Ban insider activity provides valuable insight into whether Inspire Medical is net buyers or sellers over its current business cycle. Note, Inspire Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Inspire Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Randy Ban over a month ago Disposition of 3060 shares by Randy Ban of Inspire Medical at 182.01 subject to Rule 16b-3 |
Inspire Medical Management Efficiency
The company has return on total asset (ROA) of (0.0405) % which means that it has lost $0.0405 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0396) %, meaning that it created substantial loss on money invested by shareholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of 04/24/2024, Return On Tangible Assets is likely to drop to -0.03. In addition to that, Return On Capital Employed is likely to drop to -0.07. At this time, Inspire Medical's Total Current Liabilities is relatively stable compared to the past year. As of 04/24/2024, Liabilities And Stockholders Equity is likely to grow to about 710.7 M, while Non Current Liabilities Total is likely to drop slightly above 23.1 M.Similar Executives
Found 13 records | PRESIDENT Age | ||
William Otten | HealthEquity | 52 | |
Gary Robinson | HealthEquity | 55 | |
MD FACOG | Privia Health Group | 61 | |
Larry Trittschuh | HealthEquity | 52 | |
Kevin Karas | National Research Corp | 60 | |
Steven Jackson | National Research Corp | 42 | |
Ashley Dreier | HealthEquity | 44 | |
Jonathan Soldan | HealthEquity | 32 | |
Frode Jensen | HealthEquity | 64 | |
Delano Ladd | HealthEquity | 43 | |
Edward Bloomberg | HealthEquity | 41 | |
Angelique Hill | HealthEquity | 55 | |
Edward Esq | Privia Health Group | N/A |
Management Performance
Return On Equity | -0.0396 | ||||
Return On Asset | -0.0405 |
Inspire Medical Systems Leadership Team
Elected by the shareholders, the Inspire Medical's board of directors comprises two types of representatives: Inspire Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inspire. The board's role is to monitor Inspire Medical's management team and ensure that shareholders' interests are well served. Inspire Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inspire Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Georgia GarinoisMelenikiotou, Independent Director | ||
Megan CPA, Director Reporting | ||
Timothy Herbert, President, Chief Executive Officer, Director | ||
Steven Jandrich, Chief Compliance Officer, Vice President of Human Resources | ||
Martin Abrams, Vice Experience | ||
John Rondoni, Chief Officer | ||
Shawn McCormick, Independent Director | ||
Joyce Erony, Independent Director | ||
Tim Herbert, President & CEO | ||
Ivan Lubogo, Senior Sales | ||
Marilyn Nelson, Independent Chairman of the Board | ||
Jerry Griffin, Independent Director | ||
Bryan Phillips, Senior Vice President Chief Compliance Officer, General Counsel, Company Secretary | ||
Nilesh Jagatia, CFO, Director | ||
Philip Ebeling, Chief Operating Officer | ||
Ezgi Yagci, Vice Relations | ||
Quan Ni, Vice President - Research | ||
Andreas Henke, Senior Europe | ||
Casey Tansey, Independent Director | ||
Richard Buchholz, Chief Financial Officer | ||
Randy Ban, Senior Vice President - Sales and Marketing | ||
Mudit Jain, Independent Director | ||
Chau Khuong, Independent Director | ||
Kathy Sherwood, Senior Access | ||
Gary Ellis, Independent Director | ||
John Gunn, CEO, Executive Director | ||
Carlton Weatherby, Chief Officer | ||
Randall Ban, Senior Vice President Global Sales and Marketing | ||
Dana Mead, Independent Director | ||
Shelley Broader, Independent Director | ||
Howard Greenman, Vice President of Marketing | ||
Georgia Melenikiotou, Independent Director | ||
MD FAAOS, Chief Officer | ||
Neil Luke, COO, Executive Director | ||
Steve Jandrich, Chief Compliance Officer, Vice President of Human Resources |
Inspire Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Inspire Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0396 | ||||
Return On Asset | -0.0405 | ||||
Profit Margin | (0.03) % | ||||
Operating Margin | 0.05 % | ||||
Current Valuation | 6.23 B | ||||
Shares Outstanding | 30.3 M | ||||
Shares Owned By Insiders | 1.90 % | ||||
Shares Owned By Institutions | 98.10 % | ||||
Number Of Shares Shorted | 2.08 M | ||||
Price To Earning | 15.29 X |
Inspire Medical Investors Sentiment
The influence of Inspire Medical's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Inspire. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Inspire Medical's public news can be used to forecast risks associated with an investment in Inspire. The trend in average sentiment can be used to explain how an investor holding Inspire can time the market purely based on public headlines and social activities around Inspire Medical Systems. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Inspire Medical's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Inspire Medical's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Inspire Medical's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Inspire Medical.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Inspire Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Inspire Medical's short interest history, or implied volatility extrapolated from Inspire Medical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Inspire Stock analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Inspire Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inspire Medical. If investors know Inspire will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inspire Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.682 | Earnings Share (0.72) | Revenue Per Share 21.323 | Quarterly Revenue Growth 0.396 | Return On Assets (0.04) |
The market value of Inspire Medical Systems is measured differently than its book value, which is the value of Inspire that is recorded on the company's balance sheet. Investors also form their own opinion of Inspire Medical's value that differs from its market value or its book value, called intrinsic value, which is Inspire Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inspire Medical's market value can be influenced by many factors that don't directly affect Inspire Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inspire Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inspire Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inspire Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.